Xavier Loyer Selected Research

Atherosclerosis

1/2019	MicroRNA-21 Deficiency Alters the Survival of Ly-6Clo Monocytes in ApoE-/- Mice and Reduces Early-Stage Atherosclerosis-Brief Report.
7/2017	The Dendritic Cell Receptor DNGR-1 Promotes the Development of Atherosclerosis in Mice.
1/2017	Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells.
12/2016	Genetic and Pharmacological Inhibition of TREM-1 Limits the Development of Experimental Atherosclerosis.
4/2015	MicroRNAs as therapeutic targets in atherosclerosis.
1/2014	Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.
1/2014	Microvesicles as cell-cell messengers in cardiovascular diseases.
10/2013	Natural regulatory T cells limit angiotensin II-induced aneurysm formation and rupture in mice.
3/2013	Group X secreted phospholipase A2 limits the development of atherosclerosis in LDL receptor-null mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xavier Loyer Research Topics

Disease

9	Atherosclerosis 01/2019 - 03/2013
8	Inflammation (Inflammations) 01/2020 - 01/2014
7	Myocardial Infarction 01/2020 - 10/2004
5	Heart Failure 01/2016 - 10/2004
4	Cardiomegaly (Heart Hypertrophy) 01/2020 - 10/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 03/2013
3	Ischemia 01/2020 - 08/2011
3	Hypertrophy 07/2019 - 04/2008
3	Abdominal Aortic Aneurysm 07/2019 - 10/2013
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 03/2013
3	Diabetic Cardiomyopathies 01/2017 - 09/2007
3	Heart Diseases (Heart Disease) 05/2013 - 10/2007
2	Fibrosis (Cirrhosis) 01/2020 - 12/2019
2	Aneurysm (Aneurysms) 01/2017 - 10/2013
1	Obesity 06/2021
1	Neoplasms (Cancer) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Reperfusion Injury 01/2020
1	Cicatrix (Scar) 01/2020
1	Hypoxia (Hypoxemia) 12/2019
1	Hypercholesterolemia 07/2017
1	Atherosclerotic Plaque (Atheroma) 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Thrombosis (Thrombus) 01/2017
1	Infarction (Infarctions) 01/2016
1	Chronic Limb-Threatening Ischemia 11/2014
1	Aortic Rupture 10/2013
1	Rupture 10/2013
1	Cardiomyopathies (Cardiomyopathy) 12/2008
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2006

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 07/2019 - 01/2012
5	Apolipoproteins E (ApoE)IBA 01/2019 - 02/2015
4	Biological ProductsIBA 01/2021 - 01/2014
4	Adrenergic Agents (Adrenergic Drugs)IBA 01/2017 - 10/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2015
3	CytokinesIBA 01/2020 - 01/2014
3	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 07/2019 - 10/2004
3	Nitric Oxide Synthase (NO Synthase)IBA 07/2019 - 09/2007
3	Protein Isoforms (Isoforms)IBA 07/2019 - 10/2007
3	Angiotensin IIIBA 01/2017 - 10/2013
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2017 - 09/2007
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2008 - 10/2004
2	Pharmaceutical PreparationsIBA 01/2021 - 09/2015
2	Long Noncoding RNAIBA 01/2020 - 12/2019
2	ApolipoproteinsIBA 01/2019 - 07/2017
2	Interleukin-10 (Interleukin 10)IBA 07/2017 - 10/2013
2	LDL Receptors (LDL Receptor)IBA 07/2017 - 03/2013
1	AdipokinesIBA 06/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	alpha2 Subunit Collagen Type IIBA 01/2020
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 07/2019
1	CalcineurinIBA 07/2019
1	Proteins (Proteins, Gene)FDA Link 07/2019
1	Leucine (L-Leucine)FDA Link 07/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Atorvastatin (Lipitor)FDA Link 01/2017
1	Peptides (Polypeptides)IBA 12/2016
1	nangibotideIBA 12/2016
1	LipidsIBA 11/2016
1	alpha minimal essential mediumIBA 01/2016
1	lipid phosphate phosphataseIBA 07/2015
1	Phosphatidate PhosphataseIBA 07/2015
1	lysophosphatidic acidIBA 07/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2015
1	Therapeutic UsesIBA 04/2015
1	AntagomirsIBA 04/2015
1	Lewis X AntigenIBA 11/2014
1	Becaplermin (PDGF-BB)FDA Link 11/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 01/2014
1	Kruppel-Like Factor 4IBA 01/2014
1	oxidized low density lipoproteinIBA 01/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2014
1	Monoclonal AntibodiesIBA 10/2013
1	Mitogen-Activated Protein KinasesIBA 05/2013
1	varespladib methylIBA 03/2013
1	varespladibIBA 03/2013
1	EnzymesIBA 03/2013
1	Secretory Phospholipases A2IBA 03/2013
1	Small Untranslated RNAIBA 08/2011
1	OxidesIBA 12/2008
1	phospholambanIBA 10/2008
1	CalciumIBA 06/2008
1	Tissue Kallikreins (Tissue Kallikrein)IBA 04/2008
1	Estrogens (Estrogen)FDA Link 10/2007
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2007
1	Annexin A5IBA 01/2006
1	AnnexinsIBA 01/2006

Therapy/Procedure

2	Therapeutics 01/2016 - 10/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Secondary Prevention 01/2017
1	Injections 01/2016
1	Aftercare (After-Treatment) 11/2014